BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Guido Consonni

Guido Consonni contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
MethodologyApplications

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
2topics
2close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2023arXiv

Assessing replication success via skeptical mixture priors

There is a growing interest in the analysis of replication studies of original findings across many disciplines. When testing a hypothesis for an effect size, two Bayesian approaches stand out for their principled use of the Bayes factor (BF), namely the replication BF and the skeptical BF. In particular, the latter BF is based on the skeptical prior, which represents the opinion of an investigator who is unconvinced by the original findings and wants to challenge them. We embrace the skeptical perspective, and elaborate a novel mixture prior which incorporates skepticism while at the same time controlling for prior-data conflict within the original data. Consistency properties of the resulting skeptical mixture BF are provided together with an extensive analysis of the main features of our proposal. Finally, we apply our methodology to data from the Social Sciences Replication Project. In particular we show that, for some case studies where prior-data conflict is an issue, our method uses a more realistic prior and leads to evidence-classification for replication success which differs from the standard skeptical approach.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Bayesian graphical modeling for heterogeneous causal effects

Our motivation stems from current medical research aiming at personalized treatment using a molecular-based approach. The broad goal is to develop a more precise and targeted decision making process, relative to traditional treatments based primarily on clinical diagnoses. Specifically, we consider patients affected by Acute Myeloid Leukemia (AML), an hematological cancer characterized by uncontrolled proliferation of hematopoietic stem cells in the bone marrow. Because AML responds poorly to chemoterapeutic treatments, the development of targeted therapies is essential to improve patients' prospects. In particular, the dataset we analyze contains the levels of proteins involved in cell cycle regulation and linked to the progression of the disease. We analyse treatment effects within a causal framework represented by a Directed Acyclic Graph (DAG) model, whose vertices are the protein levels in the network. A major obstacle in implementing the above program is however represented by individual heterogeneity. We address this issue through a Dirichlet Process (DP) mixture of Gaussian DAG-models where both the graphical structure as well as the allied model parameters are regarded as uncertain. Our procedure determines a clustering structure of the units reflecting the underlying heterogeneity, and produces subject-specific estimates of causal effects based on Bayesian model averaging. With reference to the AML dataset, we identify different effects of protein regulation among individuals; moreover, our method clusters patients into groups that exhibit only mild similarities with traditional categories based on morphological features.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Bayesian sample size determination for causal discovery

Graphical models based on Directed Acyclic Graphs (DAGs) are widely used to answer causal questions across a variety of scientific and social disciplines. However, observational data alone cannot distinguish in general between DAGs representing the same conditional independence assertions (Markov equivalent DAGs); as a consequence the orientation of some edges in the graph remains indeterminate. Interventional data, produced by exogenous manipulations of variables in the network, enhance the process of structure learning because they allow to distinguish among equivalent DAGs, thus sharpening causal inference. Starting from an equivalence class of DAGs, a few procedures have been devised to produce a collection of variables to be manipulated in order to identify a causal DAG. Yet, these algorithmic approaches do not determine the sample size of the interventional data required to obtain a desired level of statistical accuracy. We tackle this problem from a Bayesian experimental design perspective, taking as input a sequence of target variables to be manipulated to identify edge orientation. We then propose a method to determine, at each intervention, the optimal sample size capable of producing a successful experiment based on a pre-experimental evaluation of the overall probability of substantial correct evidence.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Bayesian causal inference in probit graphical models

We consider a binary response which is potentially affected by a set of continuous variables. Of special interest is the causal effect on the response due to an intervention on a specific variable. The latter can be meaningfully determined on the basis of observational data through suitable assumptions on the data generating mechanism. In particular we assume that the joint distribution obeys the conditional independencies (Markov properties) inherent in a Directed Acyclic Graph (DAG), and the DAG is given a causal interpretation through the notion of interventional distribution. We propose a DAG-probit model where the response is generated by discretization through a random threshold of a continuous latent variable and the latter, jointly with the remaining continuous variables, has a distribution belonging to a zero-mean Gaussian model whose covariance matrix is constrained to satisfy the Markov properties of the DAG. Our model leads to a natural definition of causal effect conditionally on a given DAG. Since the DAG which generates the observations is unknown, we present an efficient MCMC algorithm whose target is the posterior distribution on the space of DAGs, the Cholesky parameters of the concentration matrix, and the threshold linking the response to the latent. Our end result is a Bayesian Model Averaging estimate of the causal effect which incorporates parameter, as well as model, uncertainty. The methodology is assessed using simulation experiments and applied to a gene expression data set originating from breast cancer stem cells.

0 citations0 reviewsNo code linkedOpen access